HomeAI · summaries
Storia in 3 fonti
Novo Nordisk wins interim order barring SA rival from selling Ozempic copies
Interim order bars iDexis from selling weight-loss medicines containing semaglutide, the key ingredient in Ozempic and Wegovy
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
africa.businessinsider.com
South African court blocks pharmacy accused of selling unapproved Ozempic-style weight-loss drugs
A South African court has ordered pharmacy group iDexis to halt sales of semaglutide-based medicines in a legal victory for Novo Nordisk, maker of Ozempic and Wegovy
- ·
businessday.co.za
Novo Nordisk wins interim order barring SA rival from selling Ozempic copies
Interim order bars iDexis from selling weight-loss medicines containing semaglutide, the key ingredient in Ozempic and Wegovy
- ·
riotimesonline.com
A Brazilian Ozempic Rival Takes On a $1 Billion Weight-Loss Market
A Brazilian drugmaker filed to launch its own version of the blockbuster weight-loss and diabetes drug, taking aim at a market worth billions a year.
- ·
iDexis taking legal advice after court rules against it in weight-loss jab case
Novo Nordisk welcomes ruling, saying it clarifies compounding rules